Mortara Instrument Inc. began its worldwide release of its latest resting electrocardiograph (ECG), the ELI 280. The new system combines advanced ECG processing with an intuitive interface, enabling clinicians optimized efficiency in their acquisition of routine diagnostic ECGs.

With Schiller's medilog electrocardiogram (ECG) Holter recorders and the new Fire of Life software, the heart rate variability (HRV) is analyzed and displayed in a new way to help judge the function of the autonomic nervous system.

Cardea Associates announced the launch of its new electrocardiographic (ECG) device, CardeaScreen. Specifically in-tune with normal conditions for the athletic heart, CardeaScreen is designed for use during pre-participation exams (PPE) for sports participants age 14 and older. This U.S. Food and Drug Administration (FDA)-cleared device helps physicians identify abnormal cardiac conditions that could lead to sudden cardiac arrest — at a much lower cost than other ECG systems currently on the market.

Laboratory Corporation of America Holdings (LabCorp) announced it has launched its clinical next generation sequencing assay, GeneSeq: Cardio for genetic causes of familial cardiac disease.

The Society of Cardiovascular Computed Tomography (SCCT) has released a list of five interventions whose appropriateness physicians and patients should discuss as part of Choosing Wisely. The list includes:

Nuclear Imaging Choosing Wisely Five Questions Testing PET/SPECT Systems

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) released a list of specific tests that are commonly ordered—but not always necessary — in nuclear medicine and molecular imaging as part of the Choosing Wisely campaign, an initiative of the ABIM Foundation. The list identifies five targeted, evidence-based recommendations that can support conversations between patients and physicians about what care is really necessary and appropriate.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now